From a therapeutic standpoint, our study outlines a strategy to effectively reduce the nitration of the TCR complex by UA and abolish the immunosuppressive effects of CD45+EPCs during CD8+T cell adoptive transfer, thereby tipping the balance toward effective anti-tumor immunity. Here, PTPRC is linked to neoplasm.